SCAI Endorses CathWorks FFRangio Technology

SCAI Endorses CathWorks FFRangio Technology

The Society for Cardiovascular Angiography and Interventions issued expert guidance supporting the coronary assessment technology's clinical use, strengthening its evidence base.
CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

CathWorks announced today the successful completion of enrollment of the Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment randomized controlled trial.